Bringing global trials teams together
February 23, 2009Research and Development clinical trials, global
The world is getting bigger and smaller at the same time. When the internet began to really catch on about …
Roche rejoins ABPI after six-month suspension
February 23, 2009Sales and Marketing Code of Practice, Roche
Roche has been allowed to rejoin the ranks of the ABPI, after its six-month suspension for bringing discredit on the …
Shire acquires ADHD presence in Europe
February 23, 2009Sales and Marketing ADHD, Shire
Shire has bought the global rights for two established treatments for Attention Deficit Hyperactivity Disorder from UCB. The acquisition gives …
CV Therapeutics rejects Astellas takeover bid
February 23, 2009Sales and Marketing Astellas, CV Therapeutics
Biotech company CV Therapeutics has rejected a second take-over offer from Astellas, saying the Japanese group failed to recognise its …
The Pharmafocus interview: Simon Jose
February 20, 2009Sales and Marketing GlaxoSmithKline, Simon Jose, UK, partnerships, pricing
Like all his contemporaries in the UK, Simon Jose, GlaxoSmithKline’s head of UK operations has to focus on some of …
Raptiva suspended in Europe over safety concerns
February 20, 2009Research and Development, Sales and Marketing Europe, Rapitva
Psoriasis treatment Raptiva is to be suspended from use in the European Union because of concerns about rare but serious …
Servier claims victory over NICE in osteoporosis
February 19, 2009Research and Development, Sales and Marketing NICE, Servier
Servier has claimed victory in the first round of its legal battle against NICE's guidelines on osteoporosis.A judicial review requested …
GSK’s diabetes candidate enters phase III
February 19, 2009Research and Development GSK, diabetes
A large scale study of GlaxoSmithKline's type II diabetes candidate Syncria (albiglutide) has begun.Albiglutide is an investigational biological drug, and …
Anger over private firm’s role in prescribing controls
February 19, 2009NHS
Pharmacy and GP representatives have attacked plans for a private company to oversee primary care prescribing costs.Private provider Assura is …
Sanofi-Aventis joins YouTube revolution
February 18, 2009Sales and Marketing Sanofi-Aventis, diabetes
Sanofi-Aventis has launched its first YouTube channel, aimed at diabetes sufferers in the US.Reached by typing the keyword goinsulin into …
Genzyme says new plant approval is imminent
February 18, 2009Research and Development, Sales and Marketing Genzyme
Genzyme has said it expects to get approval to make a Pompe disease treatment at a new US manufacturing unit …
Novartis and charity team up on AMD campaign
February 18, 2009Medical Communications, Sales and Marketing AMD, ophthalmology
Novartis has teamed up with blindness charity the RNIB on a new campaign to promote awareness of age-related macular degeneration …
Lilly to boost biotech stake in NeuroSearch deal
February 17, 2009Research and Development Denmark, Europe, NeuroSearch
Lilly has signed a new deal with Danish biotech company NeuroSearch and increased its presence further in the biologics sector.The …
Pharma needs fresh ideas from outside industry, says Barker
February 17, 2009Research and Development, Sales and Marketing ABPI, strategy
Pharma must re-invent itself and inject new ideas into its business model by hiring talented people from outside the sector, …
Positive results halt Avastin-Tarceva trial
February 16, 2009Sales and Marketing Cancer, Roche, avastin
A phase III trial has been stopped early after promising results for Avastin and Tarceva combined as first-line maintenance treatment …
GSK: renewing the HIV pipeline
February 16, 2009Research and Development GSK, HIV
GlaxoSmithKline and Idenix are to co-develop IDX899 for the treatment of HIV infection. Despite having eight marketed HIV products, GSK …
Managers need training too
February 13, 2009Business Services management, recruitment, training
Most of us recognise that personal training and development is an essential requirement for successful career advancement, but for many …
Working Life: Kay Spiller
February 13, 2009Sales and Marketing Astellas Pharma Europe, marketing
How did you find your way into your role? This was really through what I would describe as the 'traditional' …
Bayer’s cardiovascular drug enters phase III
February 13, 2009Research and Development, Sales and Marketing Bayer, cv
Bayer Schering Pharma has begun phase III trials of riociguat for treatment of two life-threatening conditions. Two trials will investigate …
Patient surveys to be a world first for NHS
February 13, 2009Sales and Marketing NHS, PROMs, hc
Patients who have a hip replacements or varicose vein surgery on the NHS will be among the first patients to …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
